duchenn
muscular
dystrophi
dmd
common
sever
form
muscular
dystrophi
human
goal
myogen
stem
cell
transplant
therapi
dmd
increas
dystrophin
express
exist
muscl
fiber
provid
sourc
stem
cell
futur
muscl
gener
although
syngen
myogen
stem
cell
transplant
success
mice
allogen
transplant
myogen
stem
cell
ineffect
sever
human
trial
determin
whether
allogen
muscl
progenitor
cell
success
transplant
immunetoler
recipi
induc
immun
toler
two
dmdaffect
cxmd
dog
hematopoiet
cell
transplant
hct
inject
freshli
isol
musclederiv
cell
hct
donor
either
fulli
partial
chimer
xmd
recipi
restor
dystrophin
express
wildtyp
level
reduc
number
central
locat
nuclei
improv
muscl
structur
dystrophin
express
maintain
least
week
taken
togeth
data
indic
immun
toler
donor
myoblast
provid
import
platform
improv
myoblast
transplant
goal
restor
dystrophin
express
patient
dmd
duchenn
muscular
dystrophi
dmd
common
sever
form
muscular
dystrophi
human
affect
live
birth
xlink
recess
disord
caus
mutat
gene
dystrophin
largest
gene
identifi
human
genom
mutat
present
birth
yet
symptom
manifest
year
age
progress
muscl
weak
wast
forc
affect
individu
becom
wheelchairbound
year
age
succumb
diseas
third
decad
life
result
respiratori
andor
cardiac
failur
transplant
myogen
stem
cell
possess
great
potenti
longterm
repair
dystroph
muscl
inde
intramuscular
inject
adult
satellit
cellderiv
myoblast
normal
syngen
donor
mdx
mice
result
format
dystrophinposit
muscl
fiber
howev
smallscal
human
clinic
trial
reveal
intramuscular
inject
donor
myoblast
result
transient
express
dystrophin
small
number
recipi
muscl
fiber
absenc
immunosuppress
inject
donor
myoblast
trigger
cellular
immun
respons
destroy
newli
form
donor
myotub
immunosuppress
drug
cyclosporin
csp
inhibit
calcineurin
activ
prevent
graft
reject
yet
patient
treat
csp
display
increas
number
dystrophinposit
myofib
rel
patient
receiv
placebo
establish
csp
alon
potent
enough
prevent
graft
reject
addit
csp
may
neg
affect
myoblast
engraft
calcineurin
activ
essenti
myogen
differenti
vitro
vivo
import
chronic
system
immunosuppress
associ
seriou
side
effect
consider
risk
taken
togeth
observ
indic
myogen
stem
cell
transplant
therapi
requir
altern
tradit
immunosuppress
nonmyeloabl
hematopoiet
cell
transplant
hct
result
mix
chimer
defin
coexist
donor
recipi
hematopoiet
cell
clinic
nonmyeloabl
transplant
outpati
procedur
well
toler
patient
malign
nonmalign
blood
disord
mix
chimer
rodent
larg
anim
success
induc
toler
donorderiv
kidney
liver
small
bowel
heart
lung
pancreat
islet
cell
without
need
immunosuppress
specif
donor
kidney
transplant
mix
chimer
canin
recipi
fulli
function
remain
intact
least
year
even
lymphocyt
within
recipi
donor
origin
therefor
sought
determin
whether
hct
could
use
establish
immunetoler
randombr
larg
anim
model
dmd
preclin
myogen
stem
cell
transplant
studi
canin
model
dmd
cxmd
character
point
mutat
consensu
splice
acceptor
site
intron
dystrophin
gene
introduc
stop
codon
within
modifi
read
frame
result
near
complet
absenc
dystrophin
protein
dystroph
phenotyp
cxmd
canin
faith
recapitul
human
diseas
make
ideal
model
investig
potenti
therapi
hct
alon
unabl
restor
dystrophin
express
cxmd
canin
therefor
specif
ask
whether
myeloabl
nonmyeloabl
hct
cxmd
canin
would
permit
donorderiv
myogen
stem
cell
stabli
engraft
restor
dystrophin
express
hct
musclederiv
cell
transplant
protocol
bone
marrow
granulocyt
colonystimul
factor
mobil
peripher
blood
mononuclear
cell
harvest
two
normal
donor
transplant
two
irradi
leukocyt
antigenident
cxmd
recipi
figur
materi
method
hematopoiet
cell
one
cxmd
recipi
donor
deriv
tabl
full
chimera
wherea
second
recipi
mix
donor
recipi
hematopoiet
cell
tabl
mix
chimera
skelet
musclederiv
mononuclear
cell
isol
donor
process
inject
immedi
isol
cultur
day
specif
expand
myogen
cell
inject
figur
materi
method
underw
myeloabl
hct
month
age
follow
musclederiv
cell
transplant
month
age
underw
nonmyeloabl
hct
month
age
musclederiv
cell
transplant
month
age
enzymat
digest
skelet
muscl
biopsi
hct
donor
releas
mix
popul
mononuclear
cell
includ
limit
satellit
cell
fibroblast
freshli
isol
musclederiv
cell
inject
intramuscularli
sever
site
bicep
femori
muscl
chimer
recipi
cryosect
biopsi
taken
week
inject
analyz
dystrophin
express
expect
cell
inject
skelet
muscl
cxmd
chimer
dog
differenti
fusion
compet
dystrophin
express
would
restor
inde
intramuscular
inject
fresh
donor
musclederiv
cell
fulli
chimer
cxmd
recipi
restor
dystrophin
express
muscl
fiber
muscl
biopsi
taken
week
inject
figur
dystrophin
express
observ
throughout
biopsi
extend
cm
site
inject
data
shown
similarli
inject
freshli
isol
donor
musclederiv
cell
directli
muscl
mix
chimer
cxmd
canin
result
cluster
dystrophinexpress
fiber
group
near
site
inject
biopsi
week
inject
figur
express
dystrophin
appear
maintain
least
fiber
length
assess
examin
serial
section
data
shown
amount
donorderiv
wildtyp
dystrophin
messeng
rna
mrna
assess
realtim
revers
transcriptasepcr
rtpcr
use
probe
specif
recogn
wildtyp
dystrophin
splice
junction
abnorm
splice
form
cxmd
muscl
level
dystrophin
mrna
observ
wildtyp
donor
muscl
arbitrarili
set
result
rel
level
dystrophin
mrna
fulli
chimer
cxmd
recipi
musclederiv
cell
transplant
level
dystrophin
increas
significantli
p
week
inject
freshli
isol
cell
rel
level
skelet
muscl
dystrophin
mrna
musclederiv
cell
transplant
tabl
increas
p
week
inject
fresh
cell
remain
constant
week
inject
p
therefor
valu
dystrophin
express
significantli
higher
musclederiv
cell
transplant
mononuclear
satellit
cell
muscl
stem
cell
express
dystrophin
indic
donor
musclederiv
cell
differenti
dystrophinexpress
myotub
genom
dna
gdna
isol
group
cryosect
serial
cut
biopsi
inject
muscl
analyz
use
wildtyp
donor
cxmd
recipi
dog
match
intrafamili
histocompat
type
total
bodi
irradi
tbi
cgi
recipi
follow
intraven
infus
donor
bone
marrow
bm
peripher
blood
mononuclear
cell
harvest
gcsf
mobil
hematopoiet
stem
cell
bm
gpbmc
recipi
readi
donor
myoblast
transplant
stabl
hematopoiet
chimer
reach
experi
wildtyp
donor
provid
two
skelet
muscl
biopsi
normal
harvest
bicep
femori
muscl
first
skelet
muscl
biopsi
use
isol
mononuclear
cell
cultur
inject
second
skelet
muscl
biopsi
use
isol
cell
directli
inject
recipi
b
cultur
cell
separ
distinct
cell
popul
base
differenti
adher
donor
musclederiv
cell
plate
cultur
dish
hour
nonadher
cell
transfer
new
plate
adher
cell
origin
plate
refe
fresh
medium
repeat
time
interv
indic
six
distinct
popul
cell
cultur
day
maintain
confluenc
gcsf
granulocyt
colonystimul
factor
pp
preplat
variabl
number
tandem
repeatpcr
confirm
persist
signific
amount
donorderiv
cell
dna
latest
time
point
analysi
fulli
chimer
cxmd
dog
display
averag
donor
gdna
inject
repres
donor
blood
cell
nuclei
present
result
hct
tabl
ten
week
inject
freshli
isol
cell
averag
gdna
donor
deriv
p
highest
valu
donor
contribut
gdna
mix
chimer
cxmd
dog
display
averag
donor
gdna
inject
musclederiv
cell
twentyfour
week
inject
freshli
isol
cell
averag
donor
deriv
p
highest
valu
donor
contribut
gdna
determin
whether
inject
donor
musclederiv
cell
induc
immun
respons
infiltr
host
immun
cell
recipi
cryosect
immunostain
dystrophin
express
restor
fullchimer
cxmd
canin
myeloabl
bone
marrow
transplant
cxmd
recipi
follow
intramuscular
inject
musclederiv
cell
marrow
donor
cryosect
donor
muscl
recipi
muscl
preinject
recipi
muscl
week
inject
freshli
isol
cell
stain
use
antibodi
specif
dystrophin
green
dapi
use
visual
nuclei
blue
b
dystrophin
express
restor
mix
chimer
cxmd
canin
nonmyeloabl
bone
marrow
transplant
cxmd
recipi
follow
intramuscular
inject
musclederiv
cell
marrow
donor
cryosect
donor
muscl
recipi
muscl
preinject
recipi
muscl
week
inject
freshli
isol
cell
stain
use
antibodi
specif
dystrophin
green
dapi
use
visual
nuclei
blue
c
lack
immun
cell
infiltr
cxmd
recipi
muscl
inject
donor
musclederiv
cell
cryosect
donor
muscl
recipi
muscl
preinject
recipi
muscl
week
inject
fresh
cultur
cell
stain
antibodi
specif
hematopoiet
cell
green
c
macrophag
green
dapi
blue
use
visual
nuclei
use
antibodi
direct
hematopoiet
cell
marker
tcell
specif
marker
monocyt
macrophagespecif
marker
minim
hematopoiet
cell
infiltr
observ
donor
dystroph
recipi
skelet
muscl
transplant
evidenc
occasion
cell
figur
donor
recipi
preinject
absenc
cell
data
shown
yet
macrophag
clearli
observ
small
patch
within
recipi
dmdaffect
muscl
inject
figur
preinject
confirm
mild
inflammatori
process
associ
dmd
week
cell
transplant
persist
minim
lymphocyt
infiltr
observ
figur
care
examin
immunostain
cryosect
uncov
cell
data
shown
howev
small
region
cell
detect
indic
monocyt
macrophag
normal
infiltr
degener
skelet
muscl
figur
inject
therefor
inject
donor
musclederiv
cell
cxmd
muscl
induc
immun
cell
infiltr
stem
cell
therapi
effect
clinic
relev
function
must
restor
skelet
muscl
howev
local
inject
use
studi
preclud
test
function
improv
therefor
evalu
improv
muscl
structur
stabil
histolog
examin
hematoxylin
eosin
stain
cryosect
recipi
muscl
transplant
reveal
strike
loss
muscl
structur
consider
variat
muscl
fiber
size
increas
fatti
connect
tissu
compar
normal
donor
muscl
figur
recipi
preinject
inject
freshli
isol
musclederiv
cell
markedli
improv
muscl
structur
week
transplant
result
less
connect
fatti
tissu
infiltr
reduc
size
variat
fiber
diamet
compar
precel
inject
biopsi
figur
newli
form
skelet
muscl
fiber
fiber
acquir
differenti
myocyt
result
regener
character
nuclei
locat
center
muscl
fiber
donor
wildtyp
muscl
muscl
nuclei
central
locat
howev
muscl
nuclei
dmdaffect
recipi
central
locat
indic
portion
dystroph
muscl
regener
figur
inject
fresh
musclederiv
cell
reduc
number
central
locat
myonuclei
dmdaffect
recipi
muscl
statist
signific
compar
recipi
inject
p
togeth
find
suggest
engraft
donor
musclederiv
cell
restor
dystrophin
express
stabil
cxmd
muscl
prevent
repeat
attempt
regener
data
demonstr
direct
inject
freshli
isol
donorderiv
muscl
cell
engraft
without
immun
reject
chimer
recipi
howev
mani
muscl
stem
cell
transplant
procedur
requir
expans
cell
cultur
might
alter
immunogen
statu
donor
cell
therefor
determin
whether
similar
engraft
could
obtain
cell
expand
cultur
donor
musclederiv
cell
cultur
inject
bicep
femori
muscl
chimer
cxmd
recipi
use
standard
serial
preplat
techniqu
enrich
myoblast
analyz
cell
preplat
figur
order
ensur
donor
musclederiv
mononuclear
cell
myogen
adher
cell
fix
prolifer
supplementari
figur
differenti
supplementari
figur
condit
immunostain
antibodi
specif
desmin
two
marker
myoblast
cultur
establish
prolifer
cultur
cell
myogen
assess
differenti
potenti
vitro
cell
cultur
confluent
fix
addit
hour
popul
differenti
form
multinucl
myotub
express
myogenin
myosin
heavi
chain
myhc
two
marker
myogen
differenti
supplementari
figur
popul
also
express
myogenin
myosin
heavi
chain
yet
remain
primarili
mononuclear
supplementari
figur
mous
musclederiv
cell
cultur
compar
manner
exhibit
similar
result
similar
direct
inject
freshli
isol
musclederiv
cell
inject
cultur
cell
induc
immun
cell
infiltr
inject
muscl
data
shown
addit
inject
cultur
cell
restor
dystrophin
express
skelet
muscl
chimer
cxmd
recipi
figur
b
level
dystrophin
reach
maximum
wildtyp
level
fulli
chimer
dog
mix
chimer
dog
tabl
although
significantli
higher
rel
recipi
level
muscl
cell
transplant
p
p
respect
maximum
level
wildtyp
dystrophin
less
reach
inject
freshli
isol
cell
tabl
find
clinic
relev
mean
restor
longterm
express
dystrophin
skelet
muscl
continu
challeng
field
dmd
research
transplant
normal
myoblast
human
patient
unsuccess
immun
reject
donor
cell
longterm
immunosuppress
might
lengthen
muscl
cell
surviv
toxic
mani
organ
includ
kidney
liver
muscl
bone
central
nervou
system
leav
patient
vulner
opportunist
infect
studi
demonstr
hct
establish
immun
toler
cxmd
canin
permit
stabl
engraft
donor
musclederiv
cell
absenc
pharmacolog
immunosuppress
importantli
donor
musclederiv
cell
restor
dystrophin
express
least
week
follow
transplant
although
dystrophin
protein
detect
extens
throughout
cryosect
muscl
biopsi
obtain
cell
inject
level
dystrophin
transcript
rel
low
notabl
suggest
exonskip
studi
infram
dystrophin
mrna
need
achiev
total
dystrophin
level
revert
affect
muscl
mild
becker
phenotyp
howev
possibl
level
mrna
observ
may
accur
reflect
level
protein
present
although
dystrophin
protein
easili
detect
antibodi
stain
muscl
cryosect
dystrophin
estim
repres
cytoplasm
rna
present
adult
skelet
muscl
suggest
muscl
fiber
may
produc
limit
amount
dystrophin
transcript
yet
translat
messag
effici
protein
measur
level
dystrophin
transcript
may
accur
repres
level
function
dystrophin
protein
recent
studi
allogen
transplant
cultur
donor
myoblast
dmd
patient
use
highdens
inject
protocol
result
dystrophinposit
fiber
within
inject
site
area
week
transplant
one
patient
muscl
region
posit
fiber
month
transplant
protocol
reli
use
prevent
immun
reject
studi
demonstr
inject
fewer
freshli
isol
cell
result
dystrophinexpress
fiber
encompass
fiber
within
region
inject
importantli
sustain
engraft
depend
immunosuppress
crucial
distinct
side
effect
treatment
includ
tremor
hypertens
renal
dysfunct
hypomagnesemia
neurolog
toxic
longterm
toxic
liver
kidney
although
two
dog
includ
studi
import
note
result
separ
inject
site
within
dog
consist
show
similar
pattern
dystrophin
express
furthermor
dystrophin
express
clearli
restor
chimer
dog
given
hct
induc
toler
organ
kidney
lung
small
intestin
small
number
anim
studi
nonetheless
repres
definit
demonstr
allogen
toler
donor
musclederiv
cell
myeloabl
bone
marrow
transplant
cxmd
recipi
follow
intramuscular
inject
musclederiv
cell
marrow
donor
cryosect
donor
muscl
recipi
muscl
preinject
recipi
muscl
week
inject
cultur
cell
stain
use
antibodi
specif
dystrophin
green
dapi
use
visual
nuclei
blue
b
inject
cultur
cell
mix
chimer
cxmd
canin
nonmyeloabl
bone
marrow
transplant
cxmd
recipi
follow
intramuscular
inject
musclederiv
cell
marrow
donor
cryosect
donor
muscl
recipi
muscl
preinject
recipi
muscl
week
inject
cultur
cell
stain
use
antibodi
specif
dystrophin
green
dapi
use
visual
nuclei
blue
provid
import
model
improv
dystrophin
express
myogen
cell
transplant
achiev
greater
dystrophin
express
requir
improv
donor
musclederiv
cell
engraft
chimer
cxmd
canin
provid
model
optim
donor
musclederiv
cell
isol
method
test
molecul
stimul
donor
cell
prolifer
reprogram
recipi
muscl
enhanc
fusion
year
success
translat
result
canin
human
clinic
highlight
hct
clinic
relev
platform
studi
improv
myoblast
transplant
hct
institut
anim
care
use
committe
fred
hutchinson
cancer
research
center
fulli
accredit
associ
assess
accredit
laboratori
anim
care
approv
studi
elev
enclos
run
use
hous
dog
maintain
social
group
wherev
possibl
dog
enrol
veterinari
prevent
medicin
program
includ
routin
anthelmint
standard
immun
seri
canin
distemp
parvoviru
adenoviru
type
parainfluenza
viru
coronaviru
rabi
mix
breed
cxmd
canin
maintain
coloni
fred
hutchinson
cancer
research
center
previous
describ
litterm
compos
healthi
wildtyp
donor
cxmd
recipi
dog
match
intrafamili
histocompat
type
use
two
polymorph
satellit
markerson
locat
class
region
one
locat
class
ii
region
major
histocompat
complex
match
confirm
case
gene
sequenc
hct
protocol
cxmd
canin
describ
previous
day
hct
design
day
donor
marrow
cell
aspir
day
transplant
gener
anesthesia
needl
insert
humeri
femora
cryopreserv
subcutan
inject
recombin
canin
granulocyt
colonystimul
factor
mgkg
bid
gift
amgen
thousand
oak
ca
donor
day
use
mobil
hematopoiet
stem
cell
bone
marrow
peripher
blood
leukapheres
collect
granulocyt
colonystimul
factor
mobil
peripher
blood
mononuclear
cell
perform
day
use
percutan
central
duallumen
cathet
continu
flow
blood
separ
cobe
cobe
bct
lakewood
co
day
recipi
receiv
total
bodi
irradi
singl
dose
deliv
cgymin
linear
acceler
varian
clinac
palo
alto
ca
one
recipi
receiv
cgi
receiv
cgi
within
hour
total
bodi
irradi
thaw
donor
bone
marrow
cell
freshli
isol
granulocyt
colonystimul
factor
mobil
peripher
blood
mononuclear
cell
infus
intraven
postgraft
immunosuppress
consist
oral
csp
mgkg
twice
daili
day
dog
given
standard
support
care
includ
subcutan
fluid
electrolyt
system
antibiot
hematopoiet
chimer
monitor
weekli
first
week
biweekli
next
week
monthli
thereaft
donor
chimer
consid
stabl
week
hct
peripher
blood
sampl
separ
lymphocyt
granulocyt
red
blood
cell
use
ficollhypaqu
gradient
fraction
gdna
isol
lymphocyt
granulocyt
use
qiaamp
dna
mini
kit
qiagen
valencia
ca
gdna
also
isol
serial
cryosect
frozen
muscl
biopsi
use
qiaamp
dna
mini
kit
qiagen
analyz
manner
hematopoiet
chimer
specif
chimer
determin
use
fluoresc
variabl
number
tandem
repeatspcr
use
abi
prism
genet
analyz
gene
scan
softwar
appli
biosystem
foster
citi
ca
primer
specif
canin
microsatellit
polymorph
use
distinguish
donor
recipi
muscl
cell
isol
cultur
inject
experi
wildtyp
donor
provid
two
skelet
muscl
biopsi
normal
harvest
bicep
femori
muscl
first
skelet
muscl
biopsi
digest
uml
collagenas
type
sigmaaldrich
st
loui
mo
hank
balanc
salt
solut
invitrogen
carlsbad
ca
dulbecco
modifi
eagl
medium
invitrogen
carlsbad
ca
supplement
mmoll
cacl
mononuclear
cell
releas
muscl
plate
cultur
dish
maintain
growth
medium
dulbecco
modifi
eagl
medium
fetal
bovin
serum
ngml
basic
fibroblast
growth
factor
penicillin
streptomycin
lglutamin
preplat
techniqu
similar
one
describ
qupetersen
et
al
figur
use
separ
cell
popul
base
differenti
adher
cell
cultur
day
maintain
confluenc
second
skelet
muscl
biopsi
remov
donor
day
cell
inject
recipi
mononuclear
cell
isol
use
collagenas
type
howev
cell
wash
twice
phosphatebuff
salin
pb
resuspend
pb
prepar
direct
inject
fresh
cell
small
aliquot
count
assay
viabil
use
trypan
blue
exclus
adher
cell
cultur
cell
describ
earlier
harvest
use
nonenzymat
cell
dissoci
buffer
wash
twice
pb
pellet
resuspend
pb
prepar
inject
small
aliquot
count
assay
viabil
use
trypan
blue
exclus
incis
made
skin
overlay
muscl
immunetoler
cxmd
recipi
dog
inject
fascia
gentli
open
reveal
bodi
muscl
nondissolv
sutur
place
directli
muscl
five
inject
administ
muscl
surround
sutur
cover
cm
skin
sutur
monitor
daili
heal
biopsi
inject
site
anoth
incis
made
skin
muscl
surround
nondissolv
sutur
remov
muscl
biopsi
immedi
frozen
optim
cut
temperatur
use
liquid
nitrogencool
isopentan
store
immunostain
cryosect
cut
frozen
muscl
biopsi
use
leica
cryostat
adher
superfrost
slide
fisher
scientif
pittsburgh
pa
stain
section
fix
aceton
minut
allow
dri
wash
pb
section
block
block
buffer
goat
serum
bovin
serum
albumin
cold
fish
skin
gelatin
sodium
azid
moll
pb
incub
primari
antibodi
dilut
primari
antibodi
dilut
buffer
bovin
serum
albumin
cold
fish
skin
gelatin
sodium
azid
moll
pb
primari
antibodi
dystrophin
includ
vector
laboratori
burlington
ca
monoclon
antibodi
specif
dystrophin
develop
glenn
morri
obtain
development
studi
hybridoma
bank
develop
auspic
nation
institut
child
health
human
develop
maintain
univers
iowa
depart
biolog
scienc
iowa
citi
ia
primari
antibodi
use
fhcrc
biolog
seattl
wa
carpinteria
ca
fluorescein
isothiocyanateconjug
antimous
secondari
antibodi
jackson
immunoresearch
west
grove
pa
dilut
pb
section
mount
use
vectashield
contain
cultur
cell
fix
paraformaldehyd
permeabil
triton
cell
block
goat
serum
incub
primari
antibodi
dilut
primari
antibodi
dilut
buffer
primari
antibodi
specif
atsushi
kawakami
myogenin
e
wright
myosin
heavi
chain
fischman
obtain
development
studi
hybridoma
bank
monoclon
antibodi
specif
desmin
purchas
